4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-20-022256
CHIEF EXECUTIVE OFFICER bought 50,500 shares at $0.19 ($9,595)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trieu Vuong CHIEF EXECUTIVE OFFICER | 2020-11-19 | Purchase | +50,500 | $0.19 | $9,595 | 15,812,308 | D: show line 1 in the form |
| Open-market purchases · 50,500 sh · avg $0.19 · $9,595 | |||||||
Loading xslF345X03/ownership.xml…